Page 1 | Search Results | Cancer Discovery | American Association for Cancer Research

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy

Hubing Shi, Willy Hugo, Xiangju Kong, Aayoung Hong, Richard C. Koya, Gatien Moriceau, Thinle Chodon, Rongqing Guo, Douglas B. Johnson, Kimberly B. Dahlman, Mark C. Kelley, Richard F. Kefford, Bartosz Chmielowski, John A. Glaspy, Jeffrey A. Sosman, Nicolas van Baren, Georgina V. Long, Antoni Ribas, Roger S. Lo

Cancer Discov (2014) 4 (1): 80–93.

https://doi.org/10.1158/2159-8290.CD-13-0642

Published: 07 January 2014

View articletitled, Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy

Includes: Supplementary data

Journal Articles

A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition

Hubing Shi, Aayoung Hong, Xiangju Kong, Richard C. Koya, Chunying Song, Gatien Moriceau, Willy Hugo, Clarissa C. Yu, Charles Ng, Thinle Chodon, Richard A. Scolyer, Richard F. Kefford, Antoni Ribas, Georgina V. Long, Roger S. Lo

Cancer Discov (2014) 4 (1): 69–79.

https://doi.org/10.1158/2159-8290.CD-13-0279

Published: 07 January 2014

View articletitled, A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition

Includes: Supplementary data

Journal Articles

Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy

Chao Ma, Ann F. Cheung, Thinle Chodon, Richard C. Koya, Zhongqi Wu, Charles Ng, Earl Avramis, Alistair J. Cochran, Owen N. Witte, David Baltimore, Bartosz Chmielowski, James S. Economou, Begonya Comin-Anduix, Antoni Ribas, James R. Heath

Cancer Discov (2013) 3 (4): 418–429.

https://doi.org/10.1158/2159-8290.CD-12-0383

Published: 10 April 2013

View articletitled, Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy

Includes: Supplementary data

Journal Articles

Preexisting MEK1 Exon 3 Mutations in ^V600E/KBRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors

Hubing Shi, Gatien Moriceau, Xiangju Kong, Richard C. Koya, Ramin Nazarian, Gulietta M. Pupo, Antonella Bacchiocchi, Kimberly B. Dahlman, Bartosz Chmielowski, Jeffrey A. Sosman, Ruth Halaban, Richard F. Kefford, Georgina V. Long, Antoni Ribas, Roger S. Lo

Cancer Discov (2012) 2 (5): 414–424.

https://doi.org/10.1158/2159-8290.CD-12-0022

Published: 09 May 2012

View articletitled, Preexisting MEK1 Exon 3 Mutations in V600E/KBRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors

Includes: Supplementary data

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy

A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition

Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy

Preexisting MEK1 Exon 3 Mutations in ^V600E/KBRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors

Email alerts

AACR Journals

Update search

Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy

A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition

Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy

Preexisting MEK1 Exon 3 Mutations in V600E/KBRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Preexisting MEK1 Exon 3 Mutations in ^V600E/KBRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors